Tamiflu and Superinfection - a phase IV clinical study of FDA data

Summary:

Superinfection is reported only by a few people who take Tamiflu.

The phase IV clinical study analyzes which people take Tamiflu and have Superinfection. It is created by eHealthMe based on reports of 20,281 people who have side effects while taking Tamiflu from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

20,281 people reported to have side effects when taking Tamiflu.
Among them, 2 people (0.01%) have Superinfection.

What is Tamiflu?

Tamiflu has active ingredients of oseltamivir phosphate. It is often used in the flu. eHealthMe is studying from 21,207 Tamiflu users for its effectiveness, alternative drugs and more.

What is Superinfection?

Superinfection is found to be associated with 747 drugs and 458 conditions by eHealthMe.

Number of Tamiflu and Superinfection reports submitted per year:

Time on Tamiflu when people have Superinfection *:

Gender of people who have Superinfection when taking Tamiflu *:

female: 100 %
male: 0.0 %

Age of people who have Superinfection when taking Tamiflu *:

Common side effects people have besides Superinfection *:

White Blood Cell Count Decreased: 2 people, 100.00%
Viral Infection: 2 people, 100.00%
Thrombocytopenia (decrease of platelets in blood): 2 people, 100.00%
Mycoplasma Infection (bacterial infection): 2 people, 100.00%
Granulocyte Count Decreased: 2 people, 100.00%
Chills (felling of cold): 2 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tamiflu and have Superinfection?

Check whether Superinfection is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Superinfection and when was it recovered:

Superinfection in Tamiflu

Expand to all the drugs that have ingredients of oseltamivir phosphate:

Superinfection and drugs with ingredients of oseltamivir phosphate

Alternative drugs to, pros and cons of Tamiflu:

Tamiflu (21,207 reports)

Common Tamiflu side effects:

Browse all side effects of Tamiflu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Superinfection treatments and more:

Superinfection (2,279 reports)

COVID vaccines that are related to Superinfection:

Common drugs associated with Superinfection:

Prednisone: 179 reports
Omeprazole: 158 reports
Furosemide: 153 reports
Methotrexate: 118 reports

All the drugs that are associated with Superinfection:

Superinfection (747 drugs)

Common conditions associated with Superinfection:

Rheumatoid arthritis: 113 reports

All the conditions that are associated with Superinfection:

Superinfection (458 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oseltamivir phosphate (the active ingredients of Tamiflu) and Tamiflu (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.